RMEBX
Price
$62.69
Change
-$0.10 (-0.16%)
Updated
Jun 22 closing price
Net Assets
116.64B
SMVLX
Price
$93.53
Change
+$0.58 (+0.62%)
Updated
Jun 22 closing price
Net Assets
3.91B
Interact to see
Advertisement

RMEBX vs SMVLX

RMEBX vs SMVLX Comparison Chart in %
View a ticker or compare two or three
VS
RMEBX vs. SMVLX commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMEBX is a Hold and SMVLX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 117B vs. SMVLX (3.91B). SMVLX pays higher dividends than RMEBX: SMVLX (1.48) vs RMEBX (1.04). RMEBX was incepted earlier than SMVLX: RMEBX (12 years) vs SMVLX (18 years). SMVLX (1.23) is less costly to investors than RMEBX (1.07). RMEBX is a more actively managed with annual turnover of: 30.00 vs. SMVLX (16.25). RMEBX has a lower initial minimum investment than SMVLX: RMEBX (250) vs SMVLX (3000). SMVLX annual gain was more profitable for investors over the last year : 26.11 vs. RMEBX (9.11). SMVLX return over 5 years is better than : 50.40 vs. RMEBX (34.74).
RMEBXSMVLXRMEBX / SMVLX
Total Expense Ratio1.071.2387%
Annual Report Gross Expense Ratio1.071.2387%
Fund Existence12 years18 years-
Gain YTD6.30813.71446%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets117B3.91B2,992%
Annual Yield % from dividends1.041.4870%
Returns for 1 year9.1126.1135%
Returns for 3 years34.3746.3974%
Returns for 5 years34.7450.4069%
Returns for 10 years94.33174.8454%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BW17.760.38
+2.19%
Babcock & Wilcox Enterprises
GRI1.87-0.01
-0.53%
GRI Bio Inc.
RANI0.77-0.01
-1.07%
Rani Therapeutics Holdings
BWMN29.75-0.43
-1.42%
Bowman Consulting Group Ltd
NWSA24.61-0.67
-2.65%
News Corp